News

Jul 2024   A recent NYT article about cord blood banking contained very misleading statements and we have responded with corrections. Topics covered include: the fraction of cord blood units (CBU) that are contaminated, the reasons privately banked CBU are rejected from clinical trials, the odds of using cord blood for a transplant versus for clinical trial, the number of children that have been treated with privately banked cord blood, and more.

Jul 2024   The purpose of this article is to explain that, under standard operating procedures, cord blood banks normally have multiple overlapping levels of safeguards in effect to protect the samples in their storage tanks.

Jul 2024   In order to align with an upcoming clinical trial that will give unrelated cord blood to children with cerebral palsy, the Duke EAP is now offering comparable compassionate treatment to those children with cerebral palsy that do not qualify for the trial.

Jul 2024   Mason Shaffer received a cord blood transplant when he was still an infant for the rare metabolic condition Malignant Infantile Osteopetrosis. He is now living his best life as a teenager. Mason is an honors student in high school and he is very active in sports.

Jun 2024   The edge where the placenta attaches to the wall of the uterus, called the placenta decidua, contains maternal tissues. Recently, researchers in Sweden published a paper claiming that mesenchymal stromal cells from the decidua are the most effective cell therapy for graft versus host disease.  

Jun 2024   During 2023 the laboratories of cord blood banks around the world were hit with a double punch: Banks that were using Sepax were forced to change their processing method. Simultaneously, there is a shortage of the hetastarch reagent for manually depleting red cells from cord blood. As banks reconsider alternative methods of cord blood processing, the PrepaCyte®-CB reagent is now available in a semi-automated system.

May 2024   StemCyte's CEO explains why the company is ready for an IPO. In addition to operating a multi-national hybrid cord blood bank, StemCyte is also manufacturing immunotherapies from cord blood and is one of the industry's leaders in running clinical trials with cord blood.

May 2024   For generations, Indians have stored a baby's dried umbilical cord in an amulet. The new practice of cryopreserving living perinatal stem cells builds on these old customs. Marketing of family cord blood banking is very personalized in India, where sales representatives visit families in their homes.

Apr 2024   Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Apr 2024   Parents are always told that there are no biomarkers for diagnosing Autism. But they are not told that over a thousand biomarkers have been studied. To satisfy the American Psychiatric Association, a proposed biomarker would have to consistently be over 80% accurate. One of the biggest challenges in identifying biomarkers is validating them against the existing behavioral scores for autism, which do not consistently meet the 80% standard.